Various inhibitors of bone resorption (estrogen, diphosphonate compounds, and calcitonin) have been used for treatment of postmenopausal osteoporosis. The effectiveness of these therapeutic agents has been limited by their inhibition of bone formation as well as bone resorption or, in the case of calcitonin, a lack of a stimulatory effect on bone formation. As a result, bone balance after treatment with these agents is only marginally positive, The proposed research will evaluate combined treatments with endocrine or pharmacologic inhibitors of bone resorption and stimulators of bone formation to induce a greater positive bone balance for more effective restoration of lost bone mass in the estrogen-deficient state. The anabolic effects of such combined treatments will be compared to those of treatments with a single therapeutic agent. Development of treatment protocols for restoration of lost bone mass would alleviate orthopedic problems by reducing the incidence of vertebral, wrist, and hip fractures in the elderly female population. Ovariectomized rats will be untreated for the first month after surgery to allow sufficient time for the development of moderate osteopenia. These animals will then be treated with inhibitors of bone resorption (estrogen, the diphosphonate compound EHDP, or calcitonin) and a stimulator of bone formation (parathyroid hormone), singly or in combination, for periods of 30, 60, 90, or 180 days. The skeletal effects of the various treatments will be studied in cancellous bone tissue of the proximal tibial metaphysis by standard bone histomorphometric techniques. Changes in cancellous bone mass and histologic indices of bone formation, resorption, and mineralization will be measured. It is hypothesized that combined treatment with inhibitors of bone resorption and stimulators of bone formation will restore lost bone mass in the estrogen-deficient state. It is further hypothesized that such combined treatments will have a greater positive bone balance and, conse4uently, a greater anabolic effect on the skeleton than treatment with a single therapeutic agent. Validation of these hypotheses will provide a rationale for improved therapies to restore lost bone mass in, osteoporotic patients. Such a finding would mitigate the pain and suffering associated with the orthopedic complications of,osteoporosis in numerous postmenopausal women.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG009241-03
Application #
3121046
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1991-07-01
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Veterinary Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Li, M; Liang, H; Shen, Y et al. (1999) Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. Bone 24:95-100
Wronski, T J; Pun, S; Liang, H (1999) Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats. Bone 25:465-8
Westerlind, K C; Wronski, T J; Ritman, E L et al. (1997) Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci U S A 94:4199-204
Miller, S C; Hunziker, J; Mecham, M et al. (1997) Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res 76:1471-6
Baumann, B D; Wronski, T J (1995) Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247-53
Mosekilde, L; Danielsen, C C; Sogaard, C H et al. (1995) The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. Bone 16:223-30
Wronski, T J; Yen, C F (1994) Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:51-8
Westerlind, K C; Wronski, T J; Evans, G L et al. (1994) The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora. Biochem Biophys Res Commun 200:283-9
Wronski, T J; Yen, C F; Qi, H et al. (1993) Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-31